Literature DB >> 21278217

Benefit of cytoreductive nephrectomy in metastatic RCC: do we learn from retrospective studies and small prospective studies?

B Escudier1.   

Abstract

Mesh：

Year:  2011        PMID： 21278217     DOI： 10.1093/annonc/mdq654

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  3 in total

Review 1.  Targeted therapies in metastatic renal cell carcinoma: overview of the past year.

Authors:  Marine Gross-Goupil; Christophe Massard; Alain Ravaud
Journal:  Curr Urol Rep       Date:  2012-02       Impact factor: 3.092

2.  Surgical management of renal cell carcinoma: Canadian Kidney Cancer Forum Consensus.

Authors:  Ricardo A Rendon; Anil Kapoor; Rodney Breau; Michael Leveridge; Andrew Feifer; Peter C Black; Alan So
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

3.  [Systemic treatment of metastatic renal cell carcinoma: change of paradigms after introduction of targeted therapy].

Authors:  P Papavassilis; L M Krabbe; B Thielen; M Bögemann; R Moritz; I Hoffmeister; L Hertle; E Herrmann
Journal:  Urologe A       Date:  2014-04       Impact factor: 0.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.